# K073316: Cerament Bone Void Filler, Model A0210

- Pathway: 510(k) (Traditional)
- Applicant: Bonesupport AB
- Decided: Jun 20, 2008 after 207 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K960978 (1996). 13 ancestors in all.
6 later devices descend from it; 2 cite it directly.
0 of 20 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K051951: Cerament Bone Void Filler, Bonesupport AB (2005)

## Most influential descendants
- K201535: Cerament Bone Void Filler (2020), 3 descendants of its own
- K212083: Tactoset Injectable Bone Substitute (2021), 2 descendants of its own
- K223915: Tactoset (2023), 1 descendant of its own
- K090871: Cerament Ibone Void Filler High Contrast, Model a 0210-12 (2009), 1 descendant of its own
- K231968: Tactoset® Injectable Bone Substitute (2023), 0 descendants of its own

## Indications for use
CERAMENT TMIBONE VOID FILLER is a ceramic bone void filler intended only for orthopedic applications as a filler for gaps and voids that are not intrinsic to the stability of the bony structure. CERAMENT TM IBONE VOID FILLER is indicated to be injected into bony voids or gaps in the skeletal system, i.e. extremities, pelvis and spine (only during open surgery in spine). These defects may be surgically created osseous defects or osseous defects from traumatic injury to the bone. CERAMENT T MIBONE VOID FILLER provides a bone void filler that resorbs and is replaced by bone during the healing process. CERAMENT TMIBONE VOID FILLER is not intended for use in load bearing applications such as vertebroplasty or kyphoplasty.

Source page: https://510kreport.com/device/K073316
Methodology: https://510kreport.com/methodology